{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T18:44:44Z","timestamp":1769885084885,"version":"3.49.0"},"reference-count":37,"publisher":"Informa UK Limited","issue":"4","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Orbit"],"published-print":{"date-parts":[[2025,7,4]]},"DOI":"10.1080\/01676830.2025.2470989","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T09:29:46Z","timestamp":1740734986000},"page":"478-485","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":2,"title":["Selumetinib use as targeted therapy for plexiform neurofibroma: a comprehensive review of the literature"],"prefix":"10.1080","volume":"44","author":[{"given":"Hammam A.","family":"Alotaibi","sequence":"first","affiliation":[{"name":"Prince Sultan Military Medical City","place":["Riyadh, Saudi Arabia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hunter Kl.","family":"Yuen","sequence":"additional","affiliation":[{"name":"The Chinese University of Hong Kong","place":["Hong Kong, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Askar K.","family":"Alshaibani","sequence":"additional","affiliation":[{"name":"Dhahran Eye Specialist Hospital","place":["Dhahran, Saudi Arabia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eman A.","family":"Alibrahim","sequence":"additional","affiliation":[{"name":"Dhahran Eye Specialist Hospital","place":["Dhahran, Saudi Arabia"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2025,2,28]]},"reference":[{"key":"e_1_3_2_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-444-62702-5.00004-4"},{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-016-1545-1"},{"key":"e_1_3_2_4_1","unstructured":"Cotran RS Kumar V Collins T Leonard Robbins S. Robbins pathologic basis of disease - Ramzi S. Cotran Vinay Kumar Tucker Collins Stanley Leonard Robbins - google livres [Internet]. https:\/\/books.google.dz\/books\/about\/Robbins_Pathologic_Basis_of_Disease.html?id=kdhrAAAAMAAJ&redir_esc=y. Accessed May 31 2024."},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3911"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noac146"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/35065000"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.28864"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-020-00967-y"},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8628(19990326)89:1<1::AID-AJMG3>3.0.CO;2-8"},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.2013.772979"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-20-5032"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djx124"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.21037\/atm-22-1849"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1605943"},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1912735"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-017-0459-7"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-015-0314-7"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.14.4956"},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.33.9473"},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noac109"},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-09-2483"},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2008.10.026"},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(12)70270-X"},{"key":"e_1_3_2_25_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-010-9567-3"},{"issue":"8","key":"e_1_3_2_26_1","article-title":"Acneiform rash as a side effect of selumetinib in a child with neurofibromatosis type 1 treated for inoperable plexiform neurofibromas: good results with doxycycline","volume":"35","author":"Volont\u00e8 M","year":"2022","unstructured":"Volont\u00e8 M, Isoletta E, Gordon S, et al. Acneiform rash as a side effect of selumetinib in a child with neurofibromatosis type 1 treated for inoperable plexiform neurofibromas: good results with doxycycline. Dermatol Ther [Internet]. August 9, 2022;35(8). https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/dth.15607.","journal-title":"Dermatol Ther [Internet]"},{"key":"e_1_3_2_27_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12887-021-02530-5"},{"issue":"1","key":"e_1_3_2_28_1","article-title":"Selumetinib in Japanese pediatric patients with neurofibromatosis type 1 and symptomatic, inoperable plexiform neurofibromas: an open-label, phase I study","volume":"5","author":"Suenobu S","year":"2023","unstructured":"Suenobu S, Terashima K, Akiyama M, et al. Selumetinib in Japanese pediatric patients with neurofibromatosis type 1 and symptomatic, inoperable plexiform neurofibromas: an open-label, phase I study. Neurooncol Adv [Internet]. January 1, 2023;5(1). https:\/\/academic.oup.com\/noa\/article\/doi\/10.1093\/noajnl\/vdad054\/7176207.","journal-title":"Neurooncol Adv [Internet]"},{"key":"e_1_3_2_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaapos.2016.01.012"},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2023.1051026"},{"key":"e_1_3_2_31_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc4000"},{"key":"e_1_3_2_32_1","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noad086"},{"key":"e_1_3_2_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-020-03443-6"},{"issue":"1","key":"e_1_3_2_34_1","article-title":"The MEK inhibitor selumetinib reduces spinal neurofibroma burden in patients with NF1 and plexiform neurofibromas","volume":"2","author":"Jackson S","year":"2020","unstructured":"Jackson S, Baker EH, Gross AM, et al. The MEK inhibitor selumetinib reduces spinal neurofibroma burden in patients with NF1 and plexiform neurofibromas. Neurooncol Adv [Internet]. January 1, 2020;2(1). https:\/\/academic.oup.com\/noa\/article\/doi\/10.1093\/noajnl\/vdaa095\/5886209.","journal-title":"Neurooncol Adv [Internet]"},{"key":"e_1_3_2_35_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15072109"},{"key":"e_1_3_2_36_1","doi-asserted-by":"publisher","DOI":"10.1097\/IOP.0000000000002330"},{"key":"e_1_3_2_37_1","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.0000000000204446"},{"key":"e_1_3_2_38_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00381-021-05127-6"}],"container-title":["Orbit"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/01676830.2025.2470989","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T15:37:49Z","timestamp":1752593869000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/01676830.2025.2470989"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,28]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,7,4]]}},"alternative-id":["10.1080\/01676830.2025.2470989"],"URL":"https:\/\/doi.org\/10.1080\/01676830.2025.2470989","relation":{},"ISSN":["0167-6830","1744-5108"],"issn-type":[{"value":"0167-6830","type":"print"},{"value":"1744-5108","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,28]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iorb20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iorb20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-11-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-18","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-28","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}